Article Details
Retrieved on: 2021-03-01 07:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zhimeng Biopharma is developing ZM-H1505R, an oral Hepatitis B Virus capsid formation inhibitor, for treating patients with chronic hepatitis B virus ...
Article found on: www.einnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here